Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Nobuaki Matsuo is active.

Publication


Featured researches published by Nobuaki Matsuo.


Surgery Today | 1999

THE ROLE OF INTRAPULMONARY NITRIC OXIDE GENERATION IN THE DEVELOPMENT OF ADULT RESPIRATORY DISTRESS SYNDROME

Nobuaki Matsuo

This study was conducted to investigate the role of nitric oxide (NO) in the development of adult respiratory distress syndrome (ARDS). An experimental model of endotoxemia-induced ARDS was prepared in guinea pigs and the following parameters were measured: pulmonary vascular permeability, the nitrate and nitrite concentrations in blood and bronchoalveolar lavage fluid (BALF), and the activities of constitutive and inducible NO synthase in lung tissue following the administration of lipopolysaccharide (LPS). Following the intravenous administration of 0.5mg/kg LPS, the pulmonary vascular permeability increased, as did the concentrations of nitrate and nitrite in the BALF and blood. The activities of both constitutive and inducible NO synthase (NOS) increased significantly in the lung tissue 4h after the intravenous administration of LPS, the constitutive form showing significantly higher activity than the inducible form. Furthermore, the increase of vascular permeability in the lungs after LPS injection was blocked by the subcutaneous administration of NG-monomethyl-l-arginine. These observations indicate that the intrapulmonary generation of NO may play an important role in the development of ARDS.


Metabolic Brain Disease | 1992

Changes in brain ECF amino acids in rats with experimentally induced hyperammonemia.

Kenji Suzuki; Nobuaki Matsuo; Tetsuya Moriguchi; Naoshi Takeyama; Yasuhide Kitazawa; Takaya Tanaka

Using microdialysis, we studied brain extracellular fluid (ECF) amino acid metabolism in rats with experimentally induced hyperammonemia and regional elevation of brain ECF ammonia levels. The total brain ECF amino acid level was increased by an elevation of the blood ammonia level. Hyperammonemia elevated brain ECF aromatic amino acids and reduced arterial blood branched chain amino acids. When rats with hyperammonemia were intravenously administered norleucine, the brain ECF norleucine level rose markedly, suggesting increased permeability of the blood-brain barrier. When rats with hyperammonemia were infused with a branched chain amino acid-rich preparation, the elevated brain ECF aromatic amino acids level was not suppressed. Following local intracerebral ammonia infusion, only glutamate levels showed a marked elevation. These results suggest that impairment of the blood-brain barrier related to hyperammonemia increases the inflow of low molecular weight substances including amino acids. Furthermore, the ammonia-induced increase of glutamate in the cerebral ECF suggests that high ammonia levels may increase the excitability of the brain. Thus, ammonia may serve as a key factor in the onset of hepatic encephalopathy.


Thrombosis Research | 1996

Hyperammonemia inhibits platelet aggregation in rats.

Hiroshi Shinya; Nobuaki Matsuo; Naoshi Takeyama; Takaya Tanaka

The effect of hyperammonemia on ex vivo platelet function and in vivo nitric oxide synthesis was evaluated in rats. In addition, mitochondrial energy production was assessed from the fluorescence intensity of tetramethylrhodamine ethyl ester (TMRE). Continuous ammonium acetate infusion significantly reduced ex vivo platelet aggregation concomitant with a decrease of the platelet cytoplasmic ATP level. The serum level of L-arginine, as well as the levels of nitrite and nitrate (oxidative by-products of nitric oxide), increased with ammonium infusion. Prior administration of N omega-nitro-L-arginine methyl ester, a competitive inhibitor of nitric oxide synthase, did not affect the ammonia-induced rise in L-arginine, but substantially attenuated the associated decrease of platelet ATP and TMRE fluorescence as well as diminishing the anti-aggregatory effect of ammonia infusion. These findings suggest that the synthesis of nitric oxide from L-arginine is accelerated by continuous ammonium infusion and inhibits ex vivo platelet aggregation in the rat, probably by reducing mitochondrial energy production.


Surgery Today | 1989

Adrenal myelolipoma: A case report and review of the literature

Takaya Tanaka; Nobuaki Matsuo; Hiroyasu Ishikura; Daisuke Takagi; Naoshi Takeyama

A case of a 73 year old man who was preoperatively diagnosed as possibly having adrenal myelolipoma is presented herein. Adrenal myelolipoma is an uncommon benign tumor of which only 74 foreign cases and 43 Japanese cases have been previously reported in the literature dealing with surgically removed myelolipomas. The most consistent complaint of the adrenal myelolipoma sufferer is abdominal pain, caused by hemorrhaging in the tumor, and many cases are associated with obesity, hypertension and/or diabetes mellitus. There is now an increasing number of such cases being diagnosed during abdominal scanning with ultrasonography or computerized tomography for unrelated problems, whereupon the myelolipoma is usually surgically resected. With the availability of modern scanning techniques and fine needle biopsy, however, it should be possible to adopt a more conservative approach to the management of asymptomatic adrenal myelolipoma. Nevertheless, symptomatic or large tumors, must be removed since there is a high risk of spontaneous hemorrhage.


Journal of Chromatography B: Biomedical Sciences and Applications | 1989

Determination of overt carnitine palmitoyltransferase by reversed-phase high-performance liquid chromatography

Naoshi Takeyama; Nobuaki Matsuo; Daisuke Takagi; Takaya Tanaka

A method for the determination of carnitine palmitoyltransferase I (CPT I; EC 2.3.1.19) in isolated rat liver mitochondria by reversed-phase high-performance liquid chromatography is described. Enzyme activity is assayed by direct determination of coenzyme A (CoA) released from palmitoyl-CoA within 60 min by a linear gradient system. CPT 1 in rat liver mitochondria can be assayed from only 30 micrograms of mitochondrial protein per millilitre of assay mixture. The changes in the kinetic parameters of CPT I, including Ki for malonyl-CoA, resulting from the fasting-feeding cycle are also discussed.


European Surgical Research | 1993

Accelerated hepatic lipid synthesis in fasted septic rats.

Shun-ichiro Kiuchi; Nobuaki Matsuo; Naoshi Takeyama; Takaya Tanaka

We examined changes in the enzyme activities and metabolites related to hepatic fatty acid synthesis in fasted rats with sepsis produced by cecal ligation and puncture. Sepsis stimulated the in vivo incorporation of tritiated water into hepatic fatty acids and nonsaponifiable lipids. The activities of acetyl-CoA carboxylase, ATP-citrate lyase, and NADPH-generating enzymes (glucose-6-phosphate dehydrogenase and malic enzyme), the tissue levels of citrate and malonyl-CoA, and the dephosphorylation of carboxylase were increased in the livers of fasted septic rats compared with fasted sham-operated control rats. These results indicate that sepsis stimulated hepatic lipogenesis and sterologenesis in fasting rats. Furthermore, sepsis reduced the specific activity of hepatic mitochondrial carnitine palmitoyltransferase and raised that of glycerophosphate acyltransferase, suggesting an increased diversion of cytosolic acyl-CoA towards esterification. These intrahepatic metabolic changes strongly suggest that sepsis causes anabolic action on hepatic lipid metabolism.


Biochemical Journal | 1993

Oxidative damage to mitochondria is mediated by the Ca(2+)-dependent inner-membrane permeability transition.

Naoshi Takeyama; Nobuaki Matsuo; Takaya Tanaka


Journal of Analytical Toxicology | 1996

Valproic Acid Overdose and l-Carnitine Therapy

Hiroyasu Ishikura; Nobuaki Matsuo; Mineo Matsubara; Takashi Ishihara; Naoshi Takeyama; Takaya Tanaka


Nihon Kyukyu Igakukai Zasshi | 2004

Monocyte Deactivation and Altered T Helper Lymphocyte Phenotype in Septic and Traumatic Patients

Naoshi Takeyama; Takaya Tanaka; Nobuaki Matsuo; Tohru Yamamoto; Toshio Nakatani


Nihon Kyukyu Igakukai Zasshi | 2001

A Patient with Hereditary Hypocholinesterasemia

Hiroshi Shinya; Nobuaki Matsuo; Shigeru Hakoda; Akihiko Hirakawa; Toshio Nakatani; Toshikazu Hada

Collaboration


Dive into the Nobuaki Matsuo's collaboration.

Top Co-Authors

Avatar

Takaya Tanaka

Kansai Medical University

View shared research outputs
Top Co-Authors

Avatar

Naoshi Takeyama

Kansai Medical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Mineo Matsubara

Kansai Medical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Daisuke Takagi

Kansai Medical University

View shared research outputs
Top Co-Authors

Avatar

Fumihiro Nozu

Kansai Medical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Toshio Nakatani

Kansai Medical University

View shared research outputs
Researchain Logo
Decentralizing Knowledge